SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C28 - Advances in Neurogenetics

Event Time: Sunday April 23, 2017 7:00 am to 9:00 am
Topic(s): General Neurology
Director(s): Matthew Harms MD
Description: Continuing advances in genetics have led to greatly accelerated gene discovery in neurologic disorders, improving diagnosis, providing new mechanistic insights, and identifying therapeutic targets. Faculty will highlight recent technological advances and discoveries impacting the entire spectrum of neurologic diseases. In-depth focus topics will include the genetics of movement disorders and the genetics of inherited and acquired myopathies. Faculty will cover critical areas in neurogenetics, encompassing a broad spectrum of neurologic disorders that differ in their clinical manifestation, age of onset, neuroanatomical susceptibilty, and genetic mechanism. Faculty will also cover important ethical and methodological issues concerning genetic testing for neurogenetic disorders, challenges in data interpretation, and translation of neurogenetics into clinical practice.
Completion Message: Participants should obtain a broad overview of neurogenetic advances, familiarity with available tools in diagnostics, current understanding of disease mechanisms underlying hereditary developmental and degenerative neurologic disorders, treatment strategies, and expert opinions on practical and still-evolving approaches to neurogenetic disorders.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Program Speakers - Tentative

Start/End Time Title Faculty
7:00 AM - 7:15 AM Overview: Genetic Discoveries and Technological Advances Across Neurology Matthew Harms MD 
7:15 AM - 8:00 AM Focus Topic I: Genetic Advances in Movement Disorders Christine Klein MD 
8:00 AM - 8:45 AM Focus Topic II: The Genetics of Inherited and Acquired Myopathy Namita Goyal MD 
8:45 AM - 9:00 AM Questions and Answers Faculty 

Disclosures

Speaker Disclosure
Namita Goyal, MD Dr. Goyal has nothing to disclose.

Matthew Harms, MD Dr. Harms has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with University of Pennsylvania, several law firms, and Guidepoint Global.. Dr. Harms has received research support from Biogen, and the ALS Association.

Christine Klein, MD Dr. Klein has received personal compensation for activities with Centogene as a medical advisor. Dr. Klein has received personal compensation in an editorial capacity for Annals of Neurology (ANA). Dr. Klein has received (royalty or license fee or contractual rights) payments from Oxford University Press.

Register Now

Related Courses

Saturday April 21, 2018

7:00 AM-9:00 AM
C2 Functional Neurologic Disorders I: Movement, Seizures, and Speech Disorders Alberto Espay MD, FAAN
7:00 AM-4:00 PM
C6 Neurology MOC Prep Course Nicholas Johnson MD
9:30 AM-11:30 AM
C8 Emergency Neurology: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room Jose Suarez MD
C12 Functional Neurologic Disorders II: Life Experiences and Management of Functional Disorders Alberto Espay MD, FAAN
12:00 PM-1:00 PM
Navigating the Annual Meeting App Carlayne Jackson MD, FAAN
1:30 PM-3:30 PM
C22 Critical Care Consultations for Neurohospitalists Vanja Douglas MD
4:15 PM-5:30 PM
PL1 Hot Topics Plenary Session

Wednesday April 25, 2018

7:00 AM-9:00 AM
C138 Neurologic Case Studies in Pregnancy Mary O'Neal MD
9:15 AM-11:30 AM
PL5 Frontiers in Neuroscience Plenary Session
1:00 PM-3:00 PM
C143 Neurology Update I: Epilepsy, Behavioral Neurology, and Neurologic Infections Ralph Jozefowicz MD, FAAN
C147 LGBTQI Health in Neurology Holly Hinson MD, MCR
3:30 PM-5:30 PM
C159 Neurology Update II: Movement Disorders, Spine Disorders, and Sleep Disorders Ralph Jozefowicz MD, FAAN
C167 CNS Toxicities Neeraj Kumar MD

MEMBER LOG IN

Forgot Password?